4.2 Review

Gas6/TAM Receptors in Systemic Lupus Erythematosus

期刊

DISEASE MARKERS
卷 2019, 期 -, 页码 -

出版社

HINDAWI LTD
DOI: 10.1155/2019/7838195

关键词

-

资金

  1. Research Innovator Award from the College of Medicine, University of Cincinnati
  2. Junior Faculty Pilot Award from the Department of Internal Medicine, University of Cincinnati
  3. NIDDK/NIH [K01DK095067, R01DK116789]

向作者/读者索取更多资源

Systemic lupus erythematosus (SLE) is a multiorgan autoimmune disease associated with impaired immune system regulation. The exact mechanisms of SLE development remain to be elucidated. TAM receptor tyrosine kinases (RTKs) are important for apoptotic cell clearance, immune homeostasis, and resolution of immune responses. TAM deficiency leads to lupus-like autoimmune diseases. Activation of TAM receptors leads to proteolytic cleavage of the receptors, generating soluble forms of TAM. Circulating TAM receptors have an immunoregulatory function and may also serve as biomarkers for disease prognosis. Here, we review the biological function and signaling of TAM RTKs in the development and pathogenesis of lupus and lupus nephritis. Targeting Gas6/TAM pathways may be of therapeutic benefit. A discussion of potential TAM activation and inhibition in the treatment of lupus and lupus nephritis is included.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据